Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Omidria™ for Use in Cataract and Other Intraocular Lens Replacement (ILR) Procedures

Drug Name (Brand/Generic)

Omidria/ketorolac and phenylephrine

Company/Licensee

Omeros Corporation

Product Description

Combination of a mydriatic agent and an anti-inflammatory agent

Current Indication

Prevention of intraoperative miosis and reduction of postoperative pain in cataract surgery and other ILR procedures

Market Sector

Ophthalmology

Development Status

Approved in the US
Expand

Free download worth over $5000
Download our 2019 Technology, Media and Telecoms Predictions Report

Worth up to $5,850

In this report, we look at the 30 big tech themes for 2019, identifying winners and losers for each theme. This report will impact all industries helping:

  • CEOs/Senior Staff: in all industries understand the disruptive threats to their competitive landscape
  • Investors: Helps fund managers focus their time on the most interesting investment opportunities in global TM

Go Top